Legend Biotech (LEGN) Appoints Peter Salovey to its Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/23/2026
- Wall St futures ease as Big Tech earnings rekindle AI spending worries, oil jumps
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- RTX stock jumps as company lifts guidance after Q2 beat
- Dollar hits fresh 40-year high versus yen, edges higher against euro
Legend Biotech Appoints Peter Salovey, Ph.D., to its Board of Directors
August 8, 2024 4:05 PM EDTSOMERSET, N.J., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced the appointment of Peter Salovey, Ph.D., President Emeritus of Yale University, to its Board of Directors. Dr. Salovey will serve as an independent director, effective August 9.
We are pleased to welcome Dr. Salovey to the Legend Board, said Ying Huang, Ph.D., Chief Executive Officer of Legend Biotech. Dr. Saloveys deep experience and wealth of knowledge in medical research and public health will be invaluable to... More
